Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review.
prostate cancer
prostatectomy
vanishing cancer
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
23 02 2022
23 02 2022
Historique:
received:
30
01
2022
revised:
15
02
2022
accepted:
16
02
2022
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
15
4
2022
Statut:
epublish
Résumé
(1) Background: Following radical prostatectomy (RP), the absence of a demonstrable tumor on the specimen of a previously histologically proven malignancy is known as the pT0 stage. The aim of our present study is to perform a narrative review of current literature in order to determine the frequency and oncological outcomes in patients with pT0 disease. (2) Methods: A narrative review of all available literature was performed. (3) Results: The incidence of pT0 ranges between 0.07% and 1.3%. Predictors of the pT0 stage are only a single biopsy core with low-grade cancer, a cancer length not exceeding 2 mm and a high prostate volume. Biochemical recurrence ranges between 0 and 11%. (4) Conclusions: The absence of malignancy in the RP specimen despite a previous positive biopsy is a rare and unpredictable finding. Although the prognosis is considered to be excellent in most of the cases, a continued close follow-up is warranted.
Identifiants
pubmed: 35323311
pii: curroncol29030111
doi: 10.3390/curroncol29030111
pmc: PMC8946857
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1309-1315Références
J Surg Oncol. 2010 Sep 15;102(4):331-3
pubmed: 20589707
BJU Int. 2016 Sep;118(3):379-83
pubmed: 26305996
Curr Urol. 2013 Aug;7(1):14-8
pubmed: 24917750
Int J Urol. 2011 Feb;18(2):148-53
pubmed: 21198944
Urology. 2003 Sep;62(3):476-80
pubmed: 12946750
Urology. 2004 Oct;64(4):733-7
pubmed: 15491711
Eur Urol. 2004 Jan;45(1):42-5
pubmed: 14667514
Eur Urol. 2000 Dec;38(6):714-20
pubmed: 11111189
Am J Surg Pathol. 2005 Apr;29(4):467-73
pubmed: 15767799
Eur Urol. 2006 Dec;50(6):1248-52; discussion 1253
pubmed: 16828964
Korean J Urol. 2010 Jun;51(6):386-90
pubmed: 20577604
Urology. 1999 Mar;53(3):523-9
pubmed: 10096378
Urol Oncol. 2019 Oct;37(10):696-701
pubmed: 31129038
BJU Int. 2004 Jul;94(1):57-8
pubmed: 15217431
Eur Urol. 2004 Jan;45(1):36-41
pubmed: 14667513
Am J Surg Pathol. 1995 Sep;19(9):1002-9
pubmed: 7661273
Cancer. 1994 Mar 1;73(5):1472-7
pubmed: 8111715
J Urol. 2010 Mar;183(3):958-62
pubmed: 20083270
Eur Urol. 1993;24(4):461-5
pubmed: 8287886
Arch Pathol Lab Med. 2006 Jun;130(6):811-6
pubmed: 16740032
PLoS One. 2018 Dec 28;13(12):e0210037
pubmed: 30592769
Am J Surg Pathol. 1997 Feb;21(2):174-8
pubmed: 9042283